ロード中...
Meprin α combined with CEA and CA19-9 improves prognostic prediction for surgically treated colorectal cancer patients
Background: Carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) are generally used as tumour markers in patients with colorectal cancer (CRC), and meprin α might be an additional marker. Methods: The preoperative expression of serum CEA and CA19-9 was evaluated using a C12 protein...
保存先:
| 出版年: | Int J Clin Exp Pathol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
e-Century Publishing Corporation
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6965749/ https://ncbi.nlm.nih.gov/pubmed/31966381 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|